At this time, posts about L&K Bio are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 2,757 shares of L&K Bio, while institutions have sold a net 2,000 shares. L&K Bio is known as a company that develops, manufactures, and sells spinal implants.
As of 1:30 PM on the 4th, L&K Bio's stock price is 43,200 KRW, up 10.2% from the previous day, with a trading volume of 552,983 shares, which is about 30.66% of the 5-day average trading volume. On December 29, L&K Bio became a market issue with the news "Acquisition of patent rights related to spinal fusion cages... up 27%".
In addition to L&K Bio, posts by investors are also rapidly increasing for Pobis T&C (016670), Chong Kun Dang (185750), and Green Cross (006280).
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
